|
Subscribe / Renew |
|
|
Contact Us |
|
| ► Subscribe to our Free Weekly Newsletter | |
| home | Welcome, sign in or click here to subscribe. | login |
| FEATURED NOTICE | |
| City of Auburn Local Streets Preservation | |
| New Bid Calls | 8 |
| New Consultant Notices | 2 |
| New Supply Bids | 2 |
| RENTON TECHNICAL COLLEGE REMODEL OF THE 2ND & 3RD FLOORS OF BLDG. J GENCAP Construction Corp. |
| MCKNIGHT MIDDLE SCHOOL SEISMIC AND SAFETY UPGRADES Bayley Construction |
| I5 PORT OF TACOMA INTERCHANGE - PHASE 2A Flatiron Dragados Constructors Inc. |
| I-5 KOONTZ RD TO ALDER ST - PAVING Granite Construction Company |
| RENTON HIGH SCHOOL REPLACEMENT PHASE 1 MACC 01 – MAIN CONSTRUCTION BID GROUP 1, VECA JOB NO: 830417 VECA Electric & Technologies, LLC |
| more » |
| |
February 4, 2004
Cell Therapeutics, a Seattle-based biopharmaceutical company, made some personnel changes. Steve Aselage was named executive vice president, global commercial operations. Jack W. Singer, former research program chair, was named chief medical officer and Silvano Spinelli was appointed executive vice president of development and managing director of operations. Edward E. Kenney retired as chief operating officer but will remain an advisor to the CEO. Giuseppe Dastoli was named vice president, business and commercial operations - Europe. Silvia Comas will replace M. Gabriella Camboni as director of development - Europe.
MyDJC | Business | Construction | Real Estate | Architecture & Engineering | Environment | Machinery | Technology | Weekend
Copyright 2026 Seattle Daily Journal of Commerce | Terms of Service | Privacy Policy | Contact Us | Advertising | Site Index